J. Goldman & Co LP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 179 filers reported holding TG THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.2%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$5,796,315
+191.1%
233,346
+464.9%
0.21%
+229.7%
Q1 2021$1,991,000
+20.7%
41,305
+30.2%
0.06%
-23.8%
Q4 2020$1,650,000
-36.0%
31,714
-76.0%
0.08%
-47.5%
Q2 2020$2,579,000
+844.7%
132,414
+376.6%
0.16%
+384.8%
Q1 2020$273,00027,7830.03%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders